Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
sep-363856 5-ht 1a receptor NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Unipolar Depression[MeSHID:D003866]
Parkinson Disease[MeSHID:D010300]
Major Depressive Disorder[MeSHID:D003865]
Schizophrenia[MeSHID:D012559]		 NA phase 3 unknown
sep-363856 5-ht 1a receptor NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Unipolar Depression[MeSHID:D003866]
Parkinson Disease[MeSHID:D010300]
Major Depressive Disorder[MeSHID:D003865]
Schizophrenia[MeSHID:D012559]		 NA phase 3 agonist
sep-363856 5-hydroxytryptamine receptor 1a small molecule NA drugbank , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Unipolar Depression[MeSHID:D003866]
Parkinson Disease[MeSHID:D010300]
Major Depressive Disorder[MeSHID:D003865]
Schizophrenia[MeSHID:D012559]		 NA investigational agonist
sep-363856 trace amine-associated receptor 1 small molecule NA drugbank , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Unipolar Depression[MeSHID:D003866]
Parkinson Disease[MeSHID:D010300]
Major Depressive Disorder[MeSHID:D003865]
Schizophrenia[MeSHID:D012559]		 NA investigational agonist
sep-363856 trace amine-associated receptor-1 NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Unipolar Depression[MeSHID:D003866]
Parkinson Disease[MeSHID:D010300]
Major Depressive Disorder[MeSHID:D003865]
Schizophrenia[MeSHID:D012559]		 NA phase 3 unknown
sep-363856 trace amine-associated receptor-1 NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Unipolar Depression[MeSHID:D003866]
Parkinson Disease[MeSHID:D010300]
Major Depressive Disorder[MeSHID:D003865]
Schizophrenia[MeSHID:D012559]		 NA phase 3 agonist
click here to return to the previous page